Dr Reddys Laboratories (RDY) Income towards Parent Company (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Income towards Parent Company of $132.69 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 33.9% from $200.78 million a year earlier but up 183.3% from the prior quarter.
Dr Reddys Laboratories (RDY) Income towards Parent Company (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Income towards Parent Company at Dr Reddys Laboratories was $363.5 million, down 54.1% year-over-year; for FY2026 (ended Mar 31, 2026), it was $456 million, down 31.2% from FY2025.
- Annual Income towards Parent Company shows a five-year compound annual growth rate of 6.9% (FY2021 to FY2026).
- In prior fiscal years, Dr Reddys Laboratories' Income towards Parent Company was $663 million in FY2025 (-1.4%), $672.67 million in FY2024 (+19.7%), $561.73 million in FY2023 (+41.9%) and $395.73 million in FY2022 (+21.1%).
- Quarterly Income towards Parent Company has run from a low of $20.2 million in fiscal Q4 2022 to a high of $221.71 million in fiscal Q3 2025 over five years.
- On a year-over-year basis, Income towards Parent Company has declined in each of the last six quarters, with an average decline of 25.8% over the last eight quarters.
- The strongest year-over-year quarter for Income towards Parent Company in the past five years was fiscal Q4 2023, with growth of 645.5%; the weakest was fiscal Q4 2026, with a decline of 88.2%.
- According to Business Quant data, Income towards Parent Company for the three prior fiscal quarters was $46.85 million (Q1 2027), $24.08 million (Q4 2026) and $159.89 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,248.16 Bn | 1,221.78 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 670.28 Bn | 590.14 Bn | 17.30 Bn |
| 3 | AbbVie | 514.81 Bn | 482.82 Bn | 13.12 Bn |
| 4 | Merck | 363.68 Bn | 326.63 Bn | 13.19 Bn |
| 5 | Novartis Ag | 314.66 Bn | 287.90 Bn | - |
| 6 | Astrazeneca | 292.36 Bn | 266.25 Bn | 13.26 Bn |
| 7 | Amgen | 248.52 Bn | 200.18 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.74 Bn | 184.85 Bn | 6.73 Bn |
| 9 | Pfizer | 165.67 Bn | 113.03 Bn | 12.56 Bn |
| 10 | Dr Reddys Laboratories | 12.34 Bn | 11.68 Bn | 472.93 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 132.69 Mn |
| Jun 30, 2026 | 46.85 Mn |
| Mar 31, 2026 | 24.08 Mn |
| Dec 31, 2025 | 159.89 Mn |
| Sep 30, 2025 | 200.78 Mn |
| Jun 30, 2025 | 165.67 Mn |
| Mar 31, 2025 | 203.79 Mn |
| Dec 31, 2024 | 221.71 Mn |
| Sep 30, 2024 | 209.55 Mn |
| Jun 30, 2024 | 166.87 Mn |
| Mar 31, 2024 | 180.13 Mn |
| Dec 31, 2023 | 207.37 Mn |
| Sep 30, 2023 | 179.04 Mn |
| Jun 30, 2023 | 214.66 Mn |
| Mar 31, 2023 | 785.08 Mn |
| Dec 31, 2022 | 200.06 Mn |
| Sep 30, 2022 | 202.28 Mn |
| Jun 30, 2022 | 158.37 Mn |
| Mar 31, 2022 | 20.20 Mn |
| Dec 31, 2021 | 123.26 Mn |
Dr Reddys Laboratories Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();